跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-GABAPENTIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-GABAPENTIN
Authorized
STANDARD
AG-GABAPENTIN
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
abbffe9a98fad27c
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
abbffe9a98fad27c
Drug Approval Canada Name
AG-GABAPENTIN
Product Name
AG-GABAPENTIN
Status
Dormant
Status Date
2024-07-22
Original Market Date
2018-09-28
Din
02477920
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N02BF01 GABAPENTIN
Atc Name
n 02 bf 01
Aig Number
0125929003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
GABAPENTIN
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
abbffe9a98fad27c
Type
Standard
Back to Health Canada Approvals